StrideBio, Inc. logo

StrideBio, Inc.

StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies in patients. This powerful new approach has broad application, enabling gene addition, gene silencing and gene editing modalities for rare diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.stridebio.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
701 West Main Street Suite 200, NC, 27701
Durham
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/stridebio” connections=”true” suffix=””]